ECO Animal Health Group (LON:EAH) Stock Price Passes Above Fifty Day Moving Average - What's Next?

Key Points

• ECO Animal Health Group's shares surpassed their fifty-day moving average, reaching a high of GBX 75.44 ($1.01), with the last trade at GBX 73.50 ($0.98).
• Shore Capital has reiterated a "buy" rating for the stock, setting a price target of GBX 150 ($2.00).
• Insider David Hallas acquired nearly 30,000 shares at an average cost of GBX 67 ($0.90), showing confidence in the company's future performance.

ECO Animal Health Group plc (LON:EAH - Get Free Report)'s stock price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 66.10 ($0.89) and traded as high as GBX 75.44 ($1.01). ECO Animal Health Group shares last traded at GBX 73.50 ($0.99), with a volume of 55,819 shares traded.

Analysts Set New Price Targets

Separately, Shore Capital restated a "buy" rating and issued a GBX 150 ($2.02) price objective on shares of ECO Animal Health Group in a research note on Monday, July 14th.

ECO Animal Health Group Trading Down 0.6%

The company has a debt-to-equity ratio of 4.81, a current ratio of 2.96 and a quick ratio of 2.14. The business's 50-day moving average price is GBX 66.68 and its two-hundred day moving average price is GBX 61.88. The firm has a market cap of £50.47 million, a price-to-earnings ratio of 48.15 and a beta of -0.05.

ECO Animal Health Group (LON:EAH - Get Free Report) last posted its quarterly earnings data on Monday, July 14th. The company reported GBX 2.49 ($0.03) EPS for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

Insider Activity at ECO Animal Health Group

In related news, insider David Hallas purchased 29,897 shares of the firm's stock in a transaction that occurred on Tuesday, July 15th. The stock was acquired at an average cost of GBX 67 ($0.90) per share, for a total transaction of £20,030.99 ($26,930.61). 21.65% of the stock is owned by insiders.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.